Rod Humerickhouse

Rod Humerickhouse is a seasoned professional in clinical development and medical affairs, currently serving as Senior Vice President at Xencor since April 2024. Prior experience includes serving as Vice President of Hematology Development at Bristol Myers Squibb from September 2020 to April 2024, where responsibilities encompassed overseeing development strategies for multiple late-stage assets and leading cross-functional teams. Prior roles at AbbVie and Abbott Laboratories involved leadership in drug development for investigational oncology compounds, showcasing expertise in managing complex projects across multiple therapeutic areas. Rod Humerickhouse holds an M.D. and Ph.D. in Pharmacology from Indiana University School of Medicine and a Bachelor of Arts in Chemistry from Indiana University Bloomington.